organika

25 Year C-Suite Natural Food Executive Ali Samei Expands Into Leadership Role At Boosh; Set to Oversee All North American Operations

Boosh Plant-Based Brands Inc. (CSE: VEGI) ("Boosh" or the "Company") announces that Ali Samei's role with Boosh has expanded and effective immediately will be overseeing all operations as the Company prepares to expand its Canadian sales and begin exporting Boosh entrees into the USA.

Ali Samei is a highly sought after, customer-focused natural food veteran with over 25 years of experience transforming operations of emerging natural food companies into successful, profitable brands, and in numerous occasions, into nationally branded powerhouses. Some of his past and current engagements includes companies such as Yves Veggie Cuisine, Hain Celestial, Lesley Stowe's Raincoast Crisp, Hippie Snacks, Organika, The Preservatory, and UPGUYS.

"I don't recall ever seeing such a promising opportunity from both the operational side and the public side as I see with Boosh," states Ali. "I've spent a considerable amount of time with the founder and president of Boosh, Connie Marples, studying their existing operations and just as importantly, I've peppered CEO Jim Pakulis as it relates to their public structure. Here's why I chose Boosh over many other opportunities; Boosh is an emerging, young, debt-free, 100% vegan, 100% plant-based food company that recently completed a successful IPO, has less than sixteen million shares outstanding where the majority of its competitors have greater than fifty million and many over one hundred million shares outstanding. In addition, Boosh has remarkably over 1,100 retail shareholders and growing, their insider ownership is approximately 28%, and a market cap about eighty percent less than its closest competitor. Combined that with seasoned, professional management on both the operational and public side, and I truly believe it's a recipe for success," Ali continues, "At this early stage I'd stack Boosh up against some of the largest nationally recognized brands I've consulted for when they first started. That's how confident I am of Boosh and the Company's future."

"Ali is best-in-class," states Boosh's president and founder, Connie Marples. "The abundance of over-all value that Ali brings having a quarter of a century of experience in the natural food industry is tremendous. As a new member of the leadership team, we firmly believe Ali will be a tremendous asset in helping us grow from the post-start-up phase to the acceleration growth phase, and beyond."

In other news, the Company entered into a contract with Sideways Frequency on June 23rd in which the Company paid Sideways a total of One Hundred Thousand Dollars for digital marketing. The term of the contract is for three months.

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer
Telephone: (833) 882-6674

Investor Relations
Contact - Edge Communications Group
Email: invest@booshfood.com
Telephone: (236) 237-1315

About Boosh Plant-Based Brands Inc.:

Boosh Plant-Based Brands Inc., through its wholly owned subsidiary, Boosh Food, is the gateway to experiencing high quality, non-GMO, gluten free, 100% plant-based nutritional comfort foods for the whole family. We currently offer six frozen meals which are sold throughout Canada, and in the summer will be expanding our meals to include three refrigerated products. Boosh, good for you and good for planet earth.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to, the Company's proposed use of the proceeds of its initial public offering. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/88993

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Hydralyte

Waiver of ASX Listing Rule 10.1 Granted

Hydration solutions company The Hydration Pharmaceuticals Company Limited (ASX: HPC) (Hydralyte North America or the Company) refers to its announcement dated 27 March 2024 (“27 March 2024 Announcement”) where the Company advised that it had signed a variation to its facility agreement with boutique asset manager and existing substantial shareholder PURE Asset Management Pty Ltd as trustee for The Income and Growth Fund (“PURE” or “PURE Asset Management”) (“Original PURE Facility”).

Keep reading...Show less
  BPH Global Ltd

Notice of Extraordinary General Meeting/Proxy Form

Notice is hereby given that an Extraordinary General Meeting of Shareholders of BPH Global Limited ACN 009 104 330 will be held at 3:00pm AEST on 24 May 2024 at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 (Meeting).

Keep reading...Show less
Genes and chromosomes with "2024" overlay.

Biotech Market Update: Q1 2024 in Review

The first quarter of 2024 witnessed a surge in initial public offerings (IPOs) and mergers and acquisitions (M&A) within the biotech industry, signaling continued interest from investors.

AstraZeneca’s acquisition of start-up Amolyt on March 14, and its longtime biotech partner Fusion Pharmaceuticals for US$2.4 billion on March 19 marked the third acquisition of a radiopharmaceutical developer in recent months. As of writing, there have been 14 M&A deals struck in 2024, according to data from Biopharma Dive.

Investment bank Jefferies released data in early March revealing that the sector was on track to earn its highest quarterly total in three years, reflecting the cautiously optimistic outlook at this year's JPM24 conference.

Keep reading...Show less

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Planning Underway for Phase 3 Development of Tezepelumab in COPD

Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE ® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American Thoracic Society (ATS) 2024 International Conference on Monday, May 20 from 9:15-11:15 a.m. PDT .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Close up 3D rendering of DNA strands.

Biotech Stocks: 5 Biggest Companies in 2024

What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in countries all around the globe.

Plus, these big-name biotech players have pipelines stuffed with potentially disruptive products — and enough revenue to recover should some of those products fail.

This means that investors can experience the excitement of biotech investing while minimizing risk. Although returns are never guaranteed, company size can insulate investors from volatility.

Keep reading...Show less
SIRONA BIOCHEM Corporate Update April 2024

SIRONA BIOCHEM Corporate Update April 2024

Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (" Sirona " or the " Company ") provides the following update:

Dear shareholders,

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×